Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 in Neoadjuvant Prostate Cancer
NCT00657982Phase 2Unknown
- Sponsor
- Sheba Medical Center
- Start
- Apr 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in prostate cancer (PCa), sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
everolimus
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00657982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00657982.